Doctor's Bio
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: Indiana University School of Medicine
- Residency: Tulane Medical Center
Locations and Directions
Grady Memorial Hospital
OPEN 24 HOURS
Visiting hours are from 8 a.m. – 10:30 p.m. daily
Publications
- Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.
Lim KJ, Tan M, Parrondo R, Chhabra S, Schaefers C, Dooley K, De Menezes Silva Corraes A, Gupta M, Carabenciov D, Gertz M, Hwa L, Haily S, Kapoor P, Kourelis T, Warsame R, Cook J, Binder M, Abdallah N, Zanwar S, Bergsagel PL, Yadav U, Wiedmeier-Nutor E, Geyer S, Ailawadhi S, Fonseca R, Kumar S, Zekeridou A, Lin Y
Blood cancer journal. 2026;
PMID: 42728267 - BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.
Banerjee R, Hashmi H, Chaudhary PM, Atrash S, Green K, Ghosh S, Bixby T, De Wiest D, Perciavalle M, Vesole DH, Lutfi F, Jehangir W, Kaur G, Khan AM, Warsame R, Menon AP, Price MA, Guru Murthy GS, Dima D, Carney BJ, Qureshi ZP, Chhabra S
Advances in therapy. 2026;
PMID: 42618714 - High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.
Hwa YL, Jevremovic D, Pak K, Kapoor P, Visram A, Gertz MA, Dingli DD, Buadi FK, Go RS, Warsame R, Leung N, Gonsalves WI, Hobbs MA, Fonder AL, Cook JM, Binder M, Hayman SR, Kourelis T, Rajkumar SV, Dispenzieri A, Kumar SK, Muchtar E
British journal of haematology. 2026;209(3):1094-1100.
PMID: 42543782 - Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.
Mariotti EG, Kumar S, Gonsalves W, Kapoor P, Buadi F, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Gertz MA, Kourelis T, Leung N, Lin Y, Siddiqui M, Go R, Muchtar E, Warsame R, Jevremovic D, Kyle RA, Rajkumar SV, Zanwar S
Leukemia. 2026;40(10):2216-2222.
PMID: 42481797 - Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma.
Kumar S, Knopf B, Asmus E, Muchtar E, Buadi FK, Gonsalves W, Thompson M, Dingli D, Go R, Warsame R, Kourelis T, Hwa L, Fonder A, Hobbs M, Dispenzieri A, Hayman S, Leung N, Binder M, Rajkumar SV, Gertz M, Kapoor P
Blood cancer journal. 2026;
PMID: 42471354 - Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.
Lim KJC, Kumar S, Parrondo R, Chhabra S, Tan M, Dooley K, Corraes AMS, Gertz M, Hwa L, Stephens H, Kapoor P, Kourelis T, Warsame R, Cook J, Binder M, Abdallah N, Bergsagel PL, Yadav U, Wiedmeier-Nutor JE, Geyer S, Rajkumar SV, Ailawadhi S, Fonseca R, Lin Y, Zanwar S
American journal of hematology. 2026;101(9):2269-2279.
PMID: 42351384 - Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.
Yohannan B, Langworthy BW, Turner LE, Dispenzieri A, Buadi FK, Dingli D, Leung N, Kapoor P, Gonsalves WI, Kourelis T, Cook J, Binder M, Hayman SR, Lin Y, Go RS, Warsame RM, Rajkumar SV, Kumar S, Muchtar E, Alkhateeb HB, Hogan WJ, Matin A, Patnaik MM, Al-Kali A, Mangaonkar AA, Torghabeh M H, Wolf RC, Shah MV, Gertz MA
Blood cancer journal. 2026;
PMID: 42337234 - Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma.
Kumar S, Knopf B, Asmus E, Gertz M, Kapoor P, Hayman S, Roy V, Fonder A, Christenson L, Hobbs M, Bergsagel L, Fonseca R, Dingli D, Dispenzieri A, Gonsalves W, Kourelis T, Sher T, Siddiqi M, Warsame R, Ailawadhi S, Rajkumar SV, Buadi F
Clinical lymphoma, myeloma & leukemia. 2026;26(8):511-518.
PMID: 42315418 - Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype.
Rees MJ, Yohannan B, Geyer S, Atallah-Yunes SA, Toumeh N, Gertz M, Dispenzieri A, Leung N, Hayman S, Buadi F, Cook J, Dingli D, Warsame R, Kapoor P, Binder M, Kourelis T, Gonsalves W, Rajkumar SV, Kumar S, Muchtar E
British journal of haematology. 2026;209(1):149-159.
PMID: 42108212 - Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients.
Muchtar E, Geyer S, Dispenzieri A, Grogan M, Kourelis TV, Buadi FK, Kapoor P, Dingli D, Gonsalves W, Leung N, Merlini G, Rosenthal J, Boilson B, Lyle M, Frantz JG, Hayman SR, Lacy MQ, Siddiqui M, Cook J, Abdallah N, Binder M, Zanwar S, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA
JACC. CardioOncology. 2026;8(2):137-147.
PMID: 42017564
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.